Trade AstraZeneca ^AZN

Health Care Up as Traders Rotate Back Into Sector - Health Care Roundup | Morningstar

AstraZeneca Sues US Over Drugs for Medicare Price Cuts Round 2

AstraZeneca (LON:AZN) Insider Sells £40,083.12 in Stock

Jacobio signs $1.9B deal with Astrazeneca for pan-KRAS inhibitor | BioWorld

Jacobio licenses pan KRAS inhibitor to AstraZeneca

Vagus nerve-mediated neuroimmune modulation for rheumatoid arthritis: a pivotal randomized controlled trial

Jacobio Pharma Signs Agreement With AstraZeneca On Pan-KRAS Inhibitor JAB-23E73

AstraZeneca PLC $AZN Position Boosted by Benson Investment Management Company Inc.

Flputnam Investment Management Co. Increases Holdings in AstraZeneca PLC $AZN - Daily Political

Determinants of sensitivity to HER2-targeted antibody drug conjugates in urothelial cancer

Novel treatment strategies and key research priorities for patients with breast cancer and central nervous system (CNS) metastases

AstraZeneca Unit Gets Partial Win in Soliris Drug Monopoly Case

AstraZeneca PLC (AZN) Announces Approval of Saphnelo by the European Union

16,277 Shares in AstraZeneca PLC $AZN Bought by Montecito Bank & Trust

Voya Investment Management LLC Buys 770,417 Shares of AstraZeneca PLC $AZN - Daily Political

AstraZeneca's Breast Cancer Drug Datopotamab Deruxtecan Approved in India, ETPharma

15 stocks to watch on Friday: Lupin, Ola, AstraZeneca, Shriram Finance

AstraZeneca Fails to Block Colorado Contract Pharmacy Regulation

Assenagon Asset Management S.A. Sells 569,162 Shares of AstraZeneca PLC $AZN

10 Newly Overvalued Stocks this Month | Morningstar Nordics

The Bull Case For Salesforce (CRM) Could Change Following Broad Agentforce 360 Wins Across Key Sectors

Redefining gastroesophageal junction cancer care with perioperative immunotherapy, minimal residual disease monitoring and new targets

Rep. Gilbert Ray Cisneros, Jr. Buys AstraZeneca PLC (NASDAQ:AZN) Stock

Sanders Morris Harris LLC Invests $950,000 in AstraZeneca PLC $AZN

B. Riley Wealth Advisors Inc. Invests $776,000 in AstraZeneca PLC $AZN

Recent Investment Analysts' Ratings Updates for AstraZeneca (AZN) - Markets Daily

University announces new partnership with AstraZeneca and Beijing municipal parties to accelerate innovations in healthcare | PressReleasePoint

AstraZeneca PLC ADRhedged (BATS:AZNH) Declares $0.58 Annual Dividend - Markets Daily

AstraZeneca PLC (NASDAQ:AZN) Receives Consensus Recommendation of "Moderate Buy" from Analysts

AstraZeneca Announces Approval Of Saphnelo In The EU

AstraZeneca PLC $AZN Shares Acquired by Park National Corp OH - Stock Observer

AstraZeneca, Daiichi Sankyo's Enhertu Regimen Greenlit as First-line Breast Cancer Treatment in US

Beyfortus (Nirsevimab) now available in Malaysia to help protect all infants against RSV disease | Malay Mail

FDA Approves Enhertu and Perjeta Combination for First-Line HER2-Positive Breast Cancer Treatment, ETPharma

Extranodal extension in lung adenocarcinoma: pathological insights and its implication as a histological marker of clinical aggressiveness

Computational pathology in breast cancer: optimizing molecular prediction through task-oriented AI models

Based on DESTINY-Breast09 Phase III trial results that showe

Geneos Wealth Management Inc. Grows Stock Holdings in AstraZeneca PLC $AZN

US senators want the lowdown on Trump biopharma pricing deals | BioWorld

Health Innovation Hub: accelerating health equity through digital healthcare innovation

The role of circulating tumor cell-associated genes in the progression of estrogen receptor-positive breast cancer

AZN: Oncology Execution And US Manufacturing Expansion Will Drive Long-Term Upside Potential

AstraZeneca PLC $AZN Shares Bought by Cubist Systematic Strategies LLC - Markets Daily

AstraZeneca PLC $AZN Shares Bought by BI Asset Management Fondsmaeglerselskab A S

Real-world effectiveness of PARP inhibitors after CDK4/6 inhibitor therapy in BRCA-mutated HR-positive/HER2-negative advanced breast cancer

Clinical outcome and proportion of hereditary cancer genes gPV in TNBC: the HEaRTBeat study

AstraZeneca (AZN) At the Center of Serious Analyst Attention

AstraZeneca (LON:AZN) Share Price Crosses Above 200-Day Moving Average - Should You Sell?

Parkwood LLC Raises Stock Holdings in AstraZeneca PLC $AZN - Stock Observer

Astrazeneca reports data on AZD-4512 for B-cell malignancies | BioWorld

Clinical characteristics and prognostic impact of HER2 low expression in breast cancer subtypes from a Brazilian real-world cohort

Democratic senators demand details on Trump's drugmaker deals | TribLIVE.com

Top Pharmaceutical Stocks To Keep An Eye On - December 11th - Daily Political

AstraZeneca, its China joint fund lead nearly $100m financing in Syneron Bio

OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 36,387 Shares of AstraZeneca PLC $AZN - Daily Political

Why is AstraZeneca PLC (AZN) One of the Best Pharma Stocks to Invest In?

60,378 Shares in AstraZeneca PLC $AZN Bought by Norges Bank

Non-Hodgkin Lymphoma Clinical Trial Pipeline Accelerates as 180+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

US FDA launches fresh safety scrutiny of approved RSV therapies for infants | CNN

US FDA Puts Approved RSV Treatments for Infants Under New Safety Scrutiny, ETPharma

AstraZeneca PLC $AZN Shares Sold by Hsbc Holdings PLC

AstraZeneca PLC $AZN Shares Acquired by Fayez Sarofim & Co

AstraZeneca (LSE:AZN): Assessing Valuation After a Strong Year-to-Date Share Price Rally

Salesforce (CRM) Is Up 11.5% After AI Partnerships, Guidance Hike And Buybacks Completion - Has The Bull Case Changed?

AstraZeneca Announces New AI-Driven Collaboration with MENACTRIMS Aiming to Improve NMOSD Diagnosis Across the Middle East & Africa

TD Cowen Remains a Buy on AstraZeneca (AZN) | Markets Insider

The nephrotoxic effects of anti-cancer therapies: consensus report of the 34th Acute Disease Quality Initiative workgroup

Real-world analysis of immune checkpoint inhibitor efficacy and response predictors in patients treated at the CCCMunichLMU outpatient clinic

First Trust Advisors LP Acquires 217,595 Shares of AstraZeneca PLC $AZN

AstraZeneca PLC $AZN Shares Bought by Invesco Ltd.

CW Advisors LLC Increases Stake in AstraZeneca PLC $AZN

1832 Asset Management L.P. Acquires 18,543 Shares of AstraZeneca PLC $AZN

AstraZeneca to bring 10 new cancer medicines by 2030

AstraZeneca PLC $AZN Shares Sold by Capital Fund Management S.A.

Plasma proteomics to explore benefit from anti-PD-(L)1 in advanced solid tumors: a prospective pilot study

SCS Capital Management LLC Purchases 142,331 Shares of AstraZeneca PLC $AZN

Marshall Wace LLP Buys 623,902 Shares of AstraZeneca PLC $AZN

Guggenheim Capital LLC Grows Position in AstraZeneca PLC $AZN - Markets Daily

AstraZeneca PLC $AZN Shares Sold by Epoch Investment Partners Inc. - Markets Daily

Epoch Investment Partners Inc. Trims Position in AstraZeneca PLC $AZN

Neurimmune inks deal to advance NI-009 for AL amyloidosis | BioWorld

Personalized ctDNA detection and genomic profiling in the NeoRHEA Study

Has AstraZeneca's Strong 30% Rally Left Further Upside in 2025?

Monitoring protein subcellular trafficking

AstraZeneca (LON:AZN) Given "Overweight" Rating at JPMorgan Chase & Co.

European Shares Gain as Tech Rallies But FTSE 100 Lags | IG AU

AstraZeneca (LON:AZN) Earns "Overweight" Rating from JPMorgan Chase & Co. - Daily Political

Optimizing clinical monitoring and management guidelines for capivasertib in HR-positive/HER2-negative advanced breast cancer: expert opinion

Efficacy and safety of garsorasib in patients with KRAS G12C-mutated advanced pancreatic cancer

M&T Bank Corp Has $15.30 Million Stock Position in AstraZeneca PLC $AZN - Markets Daily

European Shares Gain as Tech Rallies But FTSE 100 Lags - IG UK

AstraZeneca (AZN) Named One of BofA's Top 25 Stocks for 2026

AstraZeneca share price today - Live NSE/BSE | The Economic Times

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

TEM stock price analysis: Why Tempus AI Stock Up Today?

FTSE 100 index near one-month lows as global sentiment sours

Moderna share price jumps as Oppenheimer upgrades stock

Week ahead: RBA poised to hike?

FTSE 100 Index: London stocks start week sharply lower

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk